feed,title,long_url,short_url
MedRxiv,"Preliminary report: Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, KD-414, in healthy adult participants: a non-randomized, open-label phase 2/3 clinical study in Japan",https://medrxiv.org/cgi/content/short/2022.10.27.22281603v1?rss=1,https://bit.ly/3gKbNn5
MedRxiv,Machine learning models for predicting severe COVID-19 outcomes in hospitals,https://medrxiv.org/cgi/content/short/2022.10.28.22281646v1?rss=1,https://bit.ly/3t21duR
MedRxiv,Identifying trends in SARS-CoV-2 RNA in wastewater to infer changing COVID-19 incidence: Effect of sampling frequency,https://medrxiv.org/cgi/content/short/2022.10.28.22281667v1?rss=1,https://bit.ly/3U7ct4o
MedRxiv,"Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, Canada",https://medrxiv.org/cgi/content/short/2022.10.28.22281660v1?rss=1,https://bit.ly/3fgexIL
MedRxiv,"Potential risk polarization for acute myocardial infarction during the COVID-19 pandemic: Single-center experiences in Osaka, Japan",https://medrxiv.org/cgi/content/short/2022.10.28.22281657v1?rss=1,https://bit.ly/3fhHljU
